A Maryland bill that would make the state a national test case for controlling prescription drug costs has garnered broad legislative support in Annapolis but could put the state on a legal collision course with the pharmaceutical industry.
{iframe}https://www.washingtonpost.com/amphtml/local/md-politics/maryland-weighs-new-approach-to-curbing-prescription-drug-costs/2018/02/16/781493ea-104b-11e8-9065-e55346f6de81_story.html{/iframe}